JP Patent

JP2003504338A — 胸やけの処置法

Assigned to SmithKline Beecham Corp · Expires 2003-02-04 · 23y expired

What this patent protects

(57)【要約】本発明は、胸やけ症状の処置のための、炭酸水素塩のアルカリ金属塩（好ましくは、炭酸水素ナトリウム）と有効量のプロトンポンプ阻害物質との併用に関する。

USPTO Abstract

(57)【要約】本発明は、胸やけ症状の処置のための、炭酸水素塩のアルカリ金属塩（好ましくは、炭酸水素ナトリウム）と有効量のプロトンポンプ阻害物質との併用に関する。

Drugs covered by this patent

Amoxil (amoxicillin) · Generic (originally Beecham/GSK)

Patent Metadata

Patent number: JP2003504338A
Jurisdiction: JP
Classification: —
Expires: 2003-02-04
Drug substance claim: No
Drug product claim: No
Assignee: SmithKline Beecham Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.